EP2240108A2 - Fragmentation de tissu par laser photodisruptif - Google Patents

Fragmentation de tissu par laser photodisruptif

Info

Publication number
EP2240108A2
EP2240108A2 EP09700876A EP09700876A EP2240108A2 EP 2240108 A2 EP2240108 A2 EP 2240108A2 EP 09700876 A EP09700876 A EP 09700876A EP 09700876 A EP09700876 A EP 09700876A EP 2240108 A2 EP2240108 A2 EP 2240108A2
Authority
EP
European Patent Office
Prior art keywords
laser
tissue
cells
target region
laser beam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP09700876A
Other languages
German (de)
English (en)
Other versions
EP2240108B1 (fr
EP2240108A4 (fr
Inventor
Ferenc Raksi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Lensx Inc
Original Assignee
LenSx Lasers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40845168&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2240108(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to EP18158235.4A priority Critical patent/EP3363415B1/fr
Priority to EP15163334.4A priority patent/EP2926780B1/fr
Priority to PL18158235T priority patent/PL3363415T3/pl
Priority to PL15163334T priority patent/PL2926780T3/pl
Priority to DK15163334.4T priority patent/DK2926780T3/en
Application filed by LenSx Lasers Inc filed Critical LenSx Lasers Inc
Publication of EP2240108A2 publication Critical patent/EP2240108A2/fr
Publication of EP2240108A4 publication Critical patent/EP2240108A4/fr
Publication of EP2240108B1 publication Critical patent/EP2240108B1/fr
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F9/00825—Methods or devices for eye surgery using laser for photodisruption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00736—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2217/00—General characteristics of surgical instruments
    • A61B2217/002—Auxiliary appliance
    • A61B2217/005—Auxiliary appliance with suction drainage system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00844—Feedback systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/0087—Lens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00897—Scanning mechanisms or algorithms

Definitions

  • This application relates to laser surgery techniques and systems for operating on eyes.
  • Laser light can be used to perform surgical operations on various parts of an eye for vision correction and other medical treatment. Techniques for performing such procedures with higher efficiency may provide desired benefits.
  • a method of photodisruptive laser surgery and corresponding system are provided.
  • the method of fragmenting biological tissue with a photodisruptive laser includes selecting a target region of the tissue for fragmentation, directing a beam of laser pulses to the selected target region of the tissue, and forming cells in the target region of the tissue by directing the laser beam to generate cell boundaries.
  • the tissue is a tissue of an eye.
  • the tissue is a crystalline lens of the eye.
  • the method further includes inserting an aspiration needle into the target region and removing fragmented tissue from the target region already scanned by the laser beam by using the aspiration needle.
  • the forming the cells includes forming cells with size sufficiently small to pass through the aspiration needle. [0009] In some implementations the forming the cells includes forming the cells arranged in an array.
  • the array is a regular array.
  • the regular array is one of a simple cubic lattice, a face centered lattice, a body centered lattice, a hexagonal lattice, a Bravais lattice, and a stack of two dimensional lattices.
  • the array is essentially a random array.
  • the forming the cells includes fragmenting the target tissue into cells of spheres or polyhedra. [0014] In some implementations the forming the cells includes scanning the laser beam to form multiple cells in parallel in a layer.
  • the forming the cells includes directing the laser beam to form individual cells successively.
  • the forming the cells includes scanning the laser beam to form a cell array progressing from a posterior to an anterior direction, or scanning the laser beam to form a cell array progressing from an anterior to a posterior direction.
  • the directing the laser beam to generate cell boundaries includes generating the cell boundaries by creating layers of bubbles in the target region of the tissue.
  • the creating layers of bubbles includes creating a layer of bubbles by applying a laser beam with an essentially constant power, or with a varying power.
  • the directing the beam of laser pulses includes applying the laser pulses with a laser parameter of at least one of: a pulse duration between 0.01 picosecond and 50 picoseconds, a repetition rate between 10 kiloHertz and 100 megaHertz, a pulse energy between 1 microJoule and 25 microJoule, and a pulse target separation between 0.1 micron and 50 microns.
  • the directing the beam of laser pulses comprises applying the laser pulses with a laser parameter based on a preoperative measurement of structural properties of the target region of the tissue, or an age dependent algorithm.
  • the method also includes applying additional laser pulses to one or more locations outside the target region of the tissue to create an opening for an additional procedure.
  • the method includes identifying a surgical goal, and selecting laser parameters and method features to achieve the identified surgical goal.
  • the surgical goal is an optimization of one or more of a speed of the method of fragmenting, a total amount of energy applied to the eye during the fragmenting, and a total number of generated bubbles.
  • the surgical goal is one or more of: maximization of the speed of the method of fragmenting, minimization of the total amount of energy applied to the eye during the fragmenting, and minimization of the total number of generated bubbles.
  • the method includes selecting laser parameters and method features to achieve a total time of fragmentation of one of less than 2 minutes, less than 1 minute, and less than 30 seconds.
  • the method includes selecting laser parameters and method features to achieve a ratio of a cell size to a bubble size of one of: larger than 10, larger than 100, and larger than 1000.
  • a laser system for fragmenting biological tissue includes a pulsed laser to produce a laser beam of pulses, and a laser control module to direct the laser beam to a selected target region of the tissue and to direct the laser beam to generate cell boundaries to form cells in the target region of the tissue.
  • the laser control module is configured to form cells in a regular array.
  • the laser control module formed to generate the laser pulses with laser parameters of at least one of: a pulse duration between 0.01 and 50 picoseconds, a repetition rate between 10 kHz and 100 megahertz, a pulse energy between 1 microJoule and 25 microJoule, and a pulse target separation between 0.1 micron and 50 microns.
  • a method of fragmenting a tissue in an eye with a photodisruptive laser includes selecting a target region in the eye for fragmentation, and forming an array of cells in the target region by directing a beam of laser pulses to generate cell boundaries in the target region, with a cell size and laser parameters of the laser beam such that the tissue fragmentation requires a surgical time of less than two minutes, whereas a volumetric tissue fragmentation of the same target region with the same laser parameters would require a surgical time in excess of two minutes.
  • the laser parameters are at least one of a pulse duration between 0.01 and 50 picoseconds, a repetition rate between 10 kHz and 100 MHz, a pulse energy between 1 microJoule and 25 microJoule, and a pulse target separation between 0.1 micron and 50 microns, and the cell size is between 1 microns and 50 microns.
  • FIGS, la-c illustrate a volumetric eye disruption procedure.
  • FIG. 2 illustrates an aspiration step.
  • FIG. 3 illustrates an ophthalmic surgery system
  • FIGS. 4a-b illustrate a regular cell array.
  • FIGS. 5a-d illustrate a layer-by-layer formation of a cell array.
  • FIGS. 6a-b illustrate a formation of a cell array on a cell-by -cell basis.
  • FIGS. 7a-c illustrate spherical and polyhedral cell structures.
  • This application describes examples and implementations of techniques and systems for laser surgery on the crystalline lens via photodisruption caused by laser pulses.
  • Various lens surgical procedures for removal of the crystalline lens utilize various techniques to break up the lens into small fragments that can be removed from the eye through small incisions. These procedures may use manual mechanical instruments, ultrasound, heated fluids or lasers and tend to have significant drawbacks, including the need to enter the eye with probes in order to accomplish the fragmentation, and the limited precision associated with such lens fragmentation techniques.
  • Photodisruptive laser technology can deliver laser pulses into the lens to optically fragment the lens without the insertion of a probe and thus can offer the potential for lens removal with improved control and efficiency.
  • Laser-induced photodisruption has been widely used in laser ophthalmic surgery. In particular, Nd: YAG lasers have been frequently used as the laser sources, including lens fragmentation via laser induced photodisruption.
  • laser pulses interact with the lens tissue to generate gas in form of cavitation bubbles and decrease the lens tissue transparency. Because the laser pulses are sequentially delivered into the lens, the cavitation bubbles and reduced lens tissue transparency caused by the initial laser pulses can obscure the optical path of subsequent laser pulses and thus can interfere with the delivery of subsequent laser pulses directed to additional target positions in the lens by blocking, attenuating or scattering the subsequent laser pulses. This effect can reduce the actual optical power level of the subsequent laser pulses and thus adversely affect fragmentation at the deeper locations in the lens. Some known laser-induced lens fragmentation processes do not provide effective solutions to address this technical issue.
  • the removal of a portion of or the entirety of the crystalline lens can be achieved via aspiration with reduced or no need of other lens fragmentation or modification modalities.
  • the crystalline lens has multiple optical functions in the eye, including preservation of a transparent optical path and dynamic focusing capability.
  • the lens is a unique tissue in the human body in that it continues to grow in size during gestation, after birth and throughout life. Since new lens fiber cells are added from a germinal center located on the equatorial periphery of the lens, the oldest lens fibers are located centrally in the lens. This region, called the lens nucleus, has been further subdivided into embryonal, fetal and adult nuclear zones.
  • the lens increases in diameter, it may also undergo compaction so that the properties of the nucleus are different from the cortex (Freel et al BMC Ophthalmology 2003, 3:1).
  • lens fiber cells undergo progressive loss of cytoplasmic elements and since there is no blood supply or lymphatics to supply the inner zone of the lens, it becomes progressively more difficult to preserve the optical clarity and other properties (e.g., lens flexibility) that serve the function of the lens.
  • the central core of the lens occupying the inner approximately 6-8 mm in equatorial diameter and approximately 2-3.5 mm in axial diameter.
  • This region has been shown to have reduced permeability to and from the metabolically active cortex and outer nucleus (Sweeney et al Exp Eye res, 1998:67, 587-95).
  • a correlation with this observation is the progressive loss of transparency that is identified in the most common type of cataract in the same region in patients, as well as increases in lens stiffness that occur with age in a gradient fashion from the peripheral to central portion of the lens (Heys et al Molecular Vision 2004: 10:956-63).
  • One result of such changes is the development of presbyopia and cataract that increase in severity and incidence with age.
  • FIGS, la-c illustrate an example where a photodistruptive laser system is operated to place laser pulses essentially uniformly within a surgical region, e.g., the eye lens, to be treated to allow aspiration and removal of the lens material.
  • One way to fill the volume with laser is to direct the laser pulses with a scanner to form a bubble layer and fill the entire volume with a multitude of layers, as shown in FIG. Ic.
  • FIG. 2 illustrates that after the laser treatment, an aspiration device can be used to remove the disrupted lens material.
  • the laser pulse characteristics such as their duration can range from 0.01 picoseconds (ps) to 50 picoseconds.
  • the laser pulse energy, layer, line and spot separations can be optimized to achieve the highest effectiveness of breaking up the tissue wile minimizing the effects of gas spreading, laser exposure and procedure time.
  • the threshold laser pulse parameters to achieve this can vary as well.
  • the laser energy per pulse can range from 1 micro Joule ( ⁇ j) to25 ⁇ J and the spatial pulse separation between two initial pulses adjacent in space can fall within the range of 0.1 micron to 50 microns.
  • the laser pulse duration can range from 0.01 picoseconds to 50 picoseconds and the laser repetition rate from 10 kHz to 100 MHz.
  • the parameters of the laser pulses and the scan pattern can be determined by various methods. For example, they can be based on a preoperative measurement of the lens optical or structural properties.
  • the laser energy and the spot separation can also be selected based on a preoperative measurement of lens optical or structural properties and the use of an age-dependant algorithm.
  • the pulsed laser is operated to direct a sequence of laser pulses to a target lens region of the lens to fragment the target lens region.
  • the laser pulses may also be directed to one or more regions of the lens other than the target lens region, e.g., peripheral locations and/or the lens capsule, to create an opening or incision in the lens.
  • the laser pulses can be terminated and the fragmented target lens region and any other selected portions of the lens are removed from the lens body by aspiration.
  • the following sections describe techniques and laser systems for applying laser pulses to surfaces and boundaries of cells of predetermined size, shape and spatial distribution that differ from the above described uniform volumetric distribution of the laser pulses within the treated volume.
  • the lens tissue can subsequently break up along the surfaces and boundaries of the cells.
  • the size of the cells or granules can be determined to be small enough that they can easily be removed by using e.g. an aspiration device.
  • a typical aspiration device is a needle attached to a suction pump.
  • FIG. 3 illustrates a laser surgical system for performing such a non-uniform laser distribution process.
  • An optics module 310 can focus and direct the laser beam to a target lens 301.
  • the optics module 310 can include one or more lenses and may further include one or more reflectors.
  • a control actuator can be included in the optics module 310 to adjust the focusing and the beam direction in response to a beam control signal.
  • a system control module 320 can control both a pulsed laser 302 via a laser control signal and the optics module 310 via the beam control signal.
  • An imaging device 330 may collect reflected or scattered light or sound from the target lens 301 to capture image data via the target lens 301.
  • the captured image data can then be processed by the laser system control module 320 to determine the placement of the applied laser pulses. This control can be a dynamic alignment process during the surgical process to ensure that the laser beam is properly directed at each target position.
  • the imaging device 330 can be implemented in various forms, including an optical coherent tomography (OCT) device. In other implementations, an ultrasound imaging device can also be used.
  • the system control module 320 may process image data from the imaging device 330 that includes the position offset information for the photodisruption byproducts in the target region. Based on the offset information obtained from the image data, the beam control signal can be generated to control the optics module 310, which can adjust the laser beam in response.
  • a digital processing unit can be included in the system control module 320 to perform various data processing functions for the laser alignment and laser surgery. The digital processing unit can be programmed to control the laser parameters of the initial laser pulses and the additional laser pulses, laser beam scanning direction from the posterior to anterior direction for the initial laser pulses and the laser movement of the additional laser pulses.
  • the pulsed laser 302 can be a high repetition rate pulsed laser at a pulse repetition rate of thousands of shots per second or higher with relatively low energy per pulse.
  • a laser can be operated to use relatively low energy per pulse to localize the tissue effect caused by laser-induced photodisruption.
  • a form of this tissue effect is the formation of cavitation bubbles.
  • the impacted tissue region can have a size of the order of microns or tens of microns. This localized tissue effect can improve the precision of the laser surgery and can be desirable in certain ophthalmic surgical procedures.
  • placement of many hundred, thousands or millions of contiguous or near contiguous pulses can be used to achieve certain desired surgical effect placement.
  • Such procedures using high repetition rate pulsed lasers may require high precision in positioning each pulse in the target region during surgery, both regarding their absolute position with respect to a target location and their relative position with respect to preceding pulses.
  • subsequent laser pulses may be required to be delivered next to each other with an accuracy of a few microns, when the time between pulses (the repetition rate) can be of the order of microseconds.
  • FIGS. 4a-b show an implementation of an ophthalmic surgical procedure, during which laser spots (or bubbles) are generated to form granules, the granules themselves forming a granule array.
  • the laser spots can be generated to form a regular spatial pattern of the granules, as shown in FIG. 4b.
  • Regularly spaced granules utilize the laser pulses well, since they require a limited amount of laser energy to break up a target region. Nevertheless, in other implementations the granules may form an irregular or even random array.
  • the cells can be packed next to one another. Creating the side wall of one cell can simultaneously create the side of the neighboring cell as well, making the process efficient.
  • the design of the individual cells and the cell pattern may be selected based on the physical properties of the tissue to be treated.
  • the bulk of the lens consists of concentric layers of elongated fiber cells. Cleavage of tissue parallel and perpendicular to the layers and individual fibers is different. Therefore, in some implementations a higher spot density and/or laser pulse energy can be used to form cell boundaries which are perpendicular to layers and fibers.
  • a regular pattern can be built all at once or granule by granule. Which method to use may depend on the particular laser scanner and it is a matter of optimization to achieve higher precision and shorter procedure time.
  • the granules, or cells can be cubes. With an analogy to crystal cell structures, this pattern of cells can be described as a Simple Cubic (SC) crystal. Layers of these cubes can be formed simultaneously, followed by repeating the procedure in subsequent layers.
  • SC Simple Cubic
  • FIGS. 5a-d illustrate that in some implementations first a bubble layer can be generated with the laser pulses to form the bottom layer of the SC crystal, as shown in FIG. 5a.
  • this bottom layer can be essentially transverse, or perpendicular, to an optical axis of the lens or the eye.
  • an optical axis can be defined in several different ways, with somewhat different outcomes. In what follows, the term "optical axis" will be used to refer to an axis defined by any one of these procedures, or even a compromise axis, defined as a direction falling between differently defined axes.
  • FIG. 5b illustrates that subsequent to the formation of the bottom layer, a regular array of cell walls can be generated. These walls can be essentially parallel to the optical axis, formed with a predetermined cell height.
  • FIGS. 5b and 5c illustrate that the scanner can raster, or sweep, first in one direction (FIG. 5b) then in an orthogonal direction (Fig. 5c).
  • FIG. 5d illustrates that a layer of cells can be completed by placing a bubble- layer to form the top of the cells. This "top" bubble-layer can then form the bottom bubble- layer for the next layer of cells.
  • the target volume can be filled up with a regular array of granules/cell by repeating the steps 5a-d.
  • a smooth boundary layer can be formed around the regular array of cells in the surgical target region, partially, or in its entirety. Such a boundary layer can provide a smooth surface without the raggedness of the edges of the cell array.
  • the crystalline cell array/structure can be oriented differently, the bottom layer forming any angle with the optical axis of the eye.
  • the layers themselves can be somewhat curved, to accommodate the natural curvature of the lens target region itself or the natural curvature of the focal plane of the surgical system.
  • Such structures may not be entirely regular. They may contain deformations or lattice defects. These defects can be formed intentionally or may emerge during the creation of the cell array.
  • FIGS. 6a-b illustrate an alternative implementation, where complete cells of a layer can be formed individually one after the other by controlling the scanner to form all walls of a single cell, and to start forming the next cell only after the previous cell is completed.
  • FIG. 6a illustrates that rows of cells can be formed first to build a layer of cells.
  • FIG. 6b illustrates that subsequent layers can be formed on top of already created layers, to fill a surgical target volume.
  • FIGS. 7a-c illustrate that the shape of the cells can be different from the simplest shapes, like cubes.
  • the cell array can have a hexagonal base to form a Simple Hexagonal (SH) lattice.
  • a target volume can be broken up into cells of a different type, such as spheres (FIG. 7a), separated by complementary small interstitial regions.
  • Spherical cell shapes can minimize the occurrence of clogging in the aspiration needle.
  • the type of the lattice, formed by the spherical cells can be selected to optimize the ratio of the volume of the spheres to the volume of the interstitial regions.
  • These lattice types are known as "close packed" crystals structures. Face Centered Cubic (FCC) and Hexagonal Closest Packing (HCP) are two such structures.
  • FCC Face Centered Cubic
  • HCP Hexagonal Closest Packing
  • the cells can have shapes which approximate spheres, such as polyhedral shapes.
  • the polyhedral cells can form close packed structures, analogously to the lattice of spheres.
  • FIG. 7b illustrates a Truncated Rhombic Dodecahedron, which is an example of a polyhedron approximating a sphere.
  • FIG. 7c illustrates that truncated rhombic dodecahedrons can be close packed to form a layer, and fill a target volume with a stack of layers. When passing through the aspiration needle, these polyhedra can more readily roll than cubes and the likelihood of clogging is smaller.
  • the laser scanner pattern can be optimized to speed up completion of the whole pattern. Creating individual cells with sizes of the order of 100 to 200 micrometers require small scanner displacements and can be performed at higher scanner speed. Larger scale moves of the scanner can be slower.
  • the design of the scanner can be optimized effectively for achieving the shortest overall procedure time. Applying a combination of two different scanner types, a fast small displacement scanner and a slow but larger displacement scanner, can further optimize system performance. Building cells individually is also consistent with modular software design practices.
  • a complete volumetric pattern can be created from building blocks; cells, rows and layers of cells and finally the complete pattern.
  • An analogous approach can be effective in constructing a software code for the scanner drivers as well.
  • the above described or other patterns can be created by proceeding from the posterior to the anterior side of the lens or from the anterior to the posterior side.
  • the former can be advantageous to avoid blocking the laser beam by bubbles previously formed in the target tissue.
  • the latter may be preferable when a cataract is present in the lens and penetration of laser light through the cataract is already compromised. In that case fragmentation of the anterior portion of the lens may be necessary followed by aspiration of the treated portion and successive laser treatment and aspiration of the deeper-lying parts of the lens until the full volume is fragmented.
  • Table 1 illustrates some results of the comparison, contrasting tissue breakdown by performing a volumetric method and by forming a Simple Cubic lattice of cells.
  • the volume of an individual gas bubbles is approximately proportional to the energy of the femtosecond laser pulse which created the bubble. This proportionality holds for energies not too close to the threshold of producing plasma.
  • the individual pulses are directed such that the gas bubbles touch each other. In the volumetric method this translates to the spot, line, and layer separation being approximately equal to one another, all being set by the diameter of the bubbles. In the cellular implementation this translates to the cell boundaries being formed by touching spheres. It is noted that in practice, some overlap may be necessary for both volumetric and cell-array methods.
  • Table 1 reports comparison results, varying the spot separation from 2 microns to 20 microns and the cell size from 50 microns to 300 microns.
  • the speed of the procedure was characterized by the number of pulses needed for a given total volume and the total energy needed.
  • the total energy needed to break down the tissue in the target region can be approximately independent of the size of the bubbles. This energy is of the order of 1 Joule per cubic millimeter of target volume. This relationship holds most accurately in the energy range in which the volume of an individual bubble is proportional to the laser pulse energy.
  • the speed and the corresponding energy depends both on the size of the individual bubbles and on the size of the cell.
  • the speed increases with increasing cell sizes and decreasing bubble sizes. This is the result of the change in the volume to surface ratio of the cells as a function of their size.
  • This comparison is based on using a 23 gauge needle which has inner diameter of 340 micrometers.
  • the largest size cube which can enter the tube at the least favored orientation, with its body diagonal perpendicular to the length of the tube, is about 196 micrometers.
  • Actual implementations may use smaller grain sizes, such as 150 microns.
  • the procedure time is approximately proportional to the number of bubbles created.
  • the speed improvement of the cell-array methods over the volumetric methods is proportional to the ratio R of the total number of pulses, as demonstrated in Table 1.
  • R can be approximately proportional to the Volume / Surface ratio of the cell. Since the volume of gas produced is approximately proportional to the product of the area of the cell boundaries multiplied with the bubble size, R is approximately proportional to a ratio of a cell size to a bubble size.
  • Granular fragmentation with the smallest bubble size produces the smallest amount of gas in the target tissue and uses the smallest amount of total laser energy.
  • the bubbles are closely packed, and the corresponding spot separation and line separation is nearly equal to the bubble size when creating the surface of a cell boundary.
  • the laser parameters, average power, pulse energy and repetition rate can be chosen over a wide enough range to achieve the desired bubble size, spot and line separations, the scanning system can be limited in its speed and acceleration to generate a particular pattern.
  • the linear speed of progression of the bubble placement can be kept smaller than a limiting value, v ⁇ , m .
  • v ⁇ , m a limiting value
  • T max is the maximum procedure time tolerable by the clinical environment, less than 1 minute is acceptable, less than 30 seconds is desirable, dictated mainly by the tolerance of the patient to keep still during the procedure.
  • the highest linear speed v ⁇ , m and the largest acceptable bubble size can be selected.
  • the largest acceptable bubble size is determined by the amount of gas produced, pulse energy used, and by the required precision of the surgery.
  • Some implementations of the surgical system maximize the speed of scanner and lower the laser energy threshold for the formation of cavitation bubbles, in order to minimize bubble size.
  • the surgeon has the choice to select particular parameters within the limitation of the surgical system to optimize the parameters for particular surgical outcomes.
  • the decision may take into account the size of the surgically affected area, tissue parameters the age of the patient and other factors.

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Laser Surgery Devices (AREA)

Abstract

Un procédé de chirurgie laser photodisruptif comprend la sélection d'une région cible d'un tissu pour une fragmentation, l'orientation d'un faisceau d'impulsions laser vers la région cible sélectionnée du tissu, et la formation de cellules dans la région cible du tissu en orientant le faisceau laser pour générer des frontières de cellule. Les cellules peuvent être disposées en réseaux réguliers ou irréguliers. Les cellules peuvent être générées en parallèle ou en séquence, les dimensions des cellules et les paramètres du laser réduisant considérablement la durée de l'opération chirurgicale ophtalmologique.
EP09700876.7A 2008-01-09 2009-01-09 Fragmentation de tissu par laser photodisruptif Active EP2240108B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP15163334.4A EP2926780B1 (fr) 2008-01-09 2009-01-09 Fragmentation laser photodisruptive de tissus
PL18158235T PL3363415T3 (pl) 2008-01-09 2009-01-09 Zakrzywiona fotodysrupcyjna laserowa fragmentacja tkanki
PL15163334T PL2926780T3 (pl) 2008-01-09 2009-01-09 Fotodysrupcyjna laserowa fragmentacja tkanki
DK15163334.4T DK2926780T3 (en) 2008-01-09 2009-01-09 Tissue Fragmentation Using Laser Photodispersion
EP18158235.4A EP3363415B1 (fr) 2008-01-09 2009-01-09 Fragmentation laser photodisruptive incurvée de tissus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2011508P 2008-01-09 2008-01-09
PCT/US2009/030676 WO2009089504A2 (fr) 2008-01-09 2009-01-09 Fragmentation de tissu par laser photodisruptif

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP18158235.4A Division EP3363415B1 (fr) 2008-01-09 2009-01-09 Fragmentation laser photodisruptive incurvée de tissus
EP15163334.4A Division EP2926780B1 (fr) 2008-01-09 2009-01-09 Fragmentation laser photodisruptive de tissus

Publications (3)

Publication Number Publication Date
EP2240108A2 true EP2240108A2 (fr) 2010-10-20
EP2240108A4 EP2240108A4 (fr) 2011-09-07
EP2240108B1 EP2240108B1 (fr) 2015-04-29

Family

ID=40845168

Family Applications (3)

Application Number Title Priority Date Filing Date
EP18158235.4A Active EP3363415B1 (fr) 2008-01-09 2009-01-09 Fragmentation laser photodisruptive incurvée de tissus
EP09700876.7A Active EP2240108B1 (fr) 2008-01-09 2009-01-09 Fragmentation de tissu par laser photodisruptif
EP15163334.4A Active EP2926780B1 (fr) 2008-01-09 2009-01-09 Fragmentation laser photodisruptive de tissus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP18158235.4A Active EP3363415B1 (fr) 2008-01-09 2009-01-09 Fragmentation laser photodisruptive incurvée de tissus

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP15163334.4A Active EP2926780B1 (fr) 2008-01-09 2009-01-09 Fragmentation laser photodisruptive de tissus

Country Status (10)

Country Link
US (4) US20090177189A1 (fr)
EP (3) EP3363415B1 (fr)
JP (1) JP5373820B2 (fr)
DE (1) DE112009000064T5 (fr)
DK (2) DK2926780T3 (fr)
ES (3) ES2537205T3 (fr)
PL (2) PL3363415T3 (fr)
PT (2) PT3363415T (fr)
TR (1) TR201815101T4 (fr)
WO (1) WO2009089504A2 (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8262646B2 (en) * 2006-01-20 2012-09-11 Lensar, Inc. System and method for providing the shaped structural weakening of the human lens with a laser
US9889043B2 (en) 2006-01-20 2018-02-13 Lensar, Inc. System and apparatus for delivering a laser beam to the lens of an eye
US10842675B2 (en) 2006-01-20 2020-11-24 Lensar, Inc. System and method for treating the structure of the human lens with a laser
US9545338B2 (en) 2006-01-20 2017-01-17 Lensar, Llc. System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser
WO2009033110A2 (fr) * 2007-09-05 2009-03-12 Lensx Lasers, Inc. Blindage de protection induit par laser en chirurgie laser
EP2826436B1 (fr) 2007-09-06 2018-03-28 Alcon LenSx, Inc. Ciblage précis de photocautérisation chirurgicale
WO2009033107A2 (fr) * 2007-09-06 2009-03-12 Lensx Lasers, Inc. Traitement photodisruptif du cristallin
US9456925B2 (en) * 2007-09-06 2016-10-04 Alcon Lensx, Inc. Photodisruptive laser treatment of the crystalline lens
JP2010538704A (ja) * 2007-09-10 2010-12-16 アルコン レンゼックス， インコーポレーテッド 重力場における有効なレーザ光破壊手術
US20090137991A1 (en) * 2007-09-18 2009-05-28 Kurtz Ronald M Methods and Apparatus for Laser Treatment of the Crystalline Lens
US20090137993A1 (en) * 2007-09-18 2009-05-28 Kurtz Ronald M Methods and Apparatus for Integrated Cataract Surgery
JP2011502585A (ja) * 2007-11-02 2011-01-27 アルコン レンゼックス， インコーポレーテッド 術後の眼の光学的性能を改善するための方法および装置
US8500723B2 (en) 2008-07-25 2013-08-06 Lensar, Inc. Liquid filled index matching device for ophthalmic laser procedures
US8480659B2 (en) 2008-07-25 2013-07-09 Lensar, Inc. Method and system for removal and replacement of lens material from the lens of an eye
BRPI1006739A2 (pt) * 2009-03-04 2017-06-13 Aaren Scientific Inc "método e aparelho para a geração de um mapa da córnea de um olho, método para determinação da clareza de visão de paciente, determinação da estrutura dos tecidos da região interior da córnea e determinação de um ajuste óptico para uma lente intra ocular personalizada para um paciente".
US8382745B2 (en) 2009-07-24 2013-02-26 Lensar, Inc. Laser system and method for astigmatic corrections in association with cataract treatment
US8758332B2 (en) 2009-07-24 2014-06-24 Lensar, Inc. Laser system and method for performing and sealing corneal incisions in the eye
EP2456384B1 (fr) 2009-07-24 2023-09-20 LENSAR, Inc. Système pour émettre des motifs de tir laser vers le cristallin
CN102639078B (zh) 2009-07-24 2015-10-21 能斯雅有限公司 一种为眼睛晶状体实施激光雷达辅助手术的系统和方法
US8617146B2 (en) 2009-07-24 2013-12-31 Lensar, Inc. Laser system and method for correction of induced astigmatism
US9504608B2 (en) 2009-07-29 2016-11-29 Alcon Lensx, Inc. Optical system with movable lens for ophthalmic surgical laser
US20110028957A1 (en) 2009-07-29 2011-02-03 Lensx Lasers, Inc. Optical System for Ophthalmic Surgical Laser
US8267925B2 (en) 2009-07-29 2012-09-18 Alcon Lensx, Inc. Optical system for ophthalmic surgical laser
US8262647B2 (en) 2009-07-29 2012-09-11 Alcon Lensx, Inc. Optical system for ophthalmic surgical laser
US8506559B2 (en) * 2009-11-16 2013-08-13 Alcon Lensx, Inc. Variable stage optical system for ophthalmic surgical laser
US9492322B2 (en) * 2009-11-16 2016-11-15 Alcon Lensx, Inc. Imaging surgical target tissue by nonlinear scanning
US20110166560A1 (en) * 2010-01-07 2011-07-07 Solar System Beauty Corporation Skin care laser device
EP2774587B1 (fr) * 2010-01-08 2021-10-20 AMO Development, LLC Système permettant de modifier un tissu oculaire et des lentilles intraoculaires
EP2531089B1 (fr) 2010-02-01 2023-04-05 LENSAR, Inc. Alignement fondé sur des images de purkinje d'un anneau d'aspiration dans des applications ophtalmiques
WO2011097647A1 (fr) * 2010-02-08 2011-08-11 Optimedica Corporation Système pour modification de tissu médiée par le plasma
USD694890S1 (en) 2010-10-15 2013-12-03 Lensar, Inc. Laser system for treatment of the eye
ES2937241T3 (es) 2010-10-15 2023-03-27 Lensar Inc Sistema y método de iluminación controlada por barrido de estructuras dentro de un ojo
USD695408S1 (en) 2010-10-15 2013-12-10 Lensar, Inc. Laser system for treatment of the eye
EP2672926B1 (fr) * 2011-03-21 2017-05-31 Adventus Technology, Inc. Restauration de l'accommodation par remplissage du cristallin
US10463541B2 (en) 2011-03-25 2019-11-05 Lensar, Inc. System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions
US10716706B2 (en) 2011-04-07 2020-07-21 Bausch & Lomb Incorporated System and method for performing lens fragmentation
US8459794B2 (en) 2011-05-02 2013-06-11 Alcon Lensx, Inc. Image-processor-controlled misalignment-reduction for ophthalmic systems
US9622913B2 (en) 2011-05-18 2017-04-18 Alcon Lensx, Inc. Imaging-controlled laser surgical system
US9066784B2 (en) * 2011-12-19 2015-06-30 Alcon Lensx, Inc. Intra-surgical optical coherence tomographic imaging of cataract procedures
TWI554244B (zh) * 2011-12-19 2016-10-21 愛爾康眼科手術激光股份有限公司 用於雷射白內障程序之手術內光學同調斷層掃描成像的影像處理器
US9023016B2 (en) * 2011-12-19 2015-05-05 Alcon Lensx, Inc. Image processor for intra-surgical optical coherence tomographic imaging of laser cataract procedures
US10182943B2 (en) 2012-03-09 2019-01-22 Alcon Lensx, Inc. Adjustable pupil system for surgical laser systems
US8852177B2 (en) 2012-03-09 2014-10-07 Alcon Lensx, Inc. Spatio-temporal beam modulator for surgical laser systems
JP6295567B2 (ja) * 2012-10-01 2018-03-20 株式会社ニデック 眼科手術用超音波チップ
US9592157B2 (en) 2012-11-09 2017-03-14 Bausch & Lomb Incorporated System and method for femto-fragmentation of a crystalline lens
WO2014158618A1 (fr) * 2013-03-12 2014-10-02 Bausch & Lomb Incorporated Système et procédé pour configurer des segments de fragmentation d'un cristallin pour une lensectomie
JP6143289B2 (ja) * 2013-07-16 2017-06-07 国立研究開発法人理化学研究所 水晶体の弾性測定方法、水晶体の弾性測定装置、及び水晶体の老視判定装置
CN106413634B (zh) 2013-11-01 2019-03-05 雷恩斯根公司 双部件调节性人工晶状体设备
US10004596B2 (en) 2014-07-31 2018-06-26 Lensgen, Inc. Accommodating intraocular lens device
FR3026940B1 (fr) 2014-10-08 2021-09-03 Univ Jean Monnet Dispositif et procede pour la decoupe d'une cornee ou d'un cristallin
US10485705B2 (en) * 2015-07-01 2019-11-26 Optimedica Corporation Sub-nanosecond laser cataract surgery system
US11083625B2 (en) 2015-07-01 2021-08-10 Amo Development, Llc Sub-nanosecond laser surgery system utilizing multiple pulsed laser beams
DE102015212877A1 (de) 2015-07-09 2017-01-12 Carl Zeiss Meditec Ag Anordnung und Verfahren zur Bearbeitung einer Fläche in einem Bearbeitungsvolumen eines transparenten Materials mittels einer fokussierten Strahlung
CN113180886A (zh) 2015-12-01 2021-07-30 雷恩斯根公司 调节性人工晶状体装置
RU2736181C2 (ru) 2016-04-06 2020-11-12 Керанова Оптический сканер аппарата для разрезания ткани человека или животного
CN106788728B (zh) * 2017-01-16 2019-06-21 中国科学技术大学 强光干扰下的光信号检测方法
JP7385558B2 (ja) 2017-10-17 2023-11-22 アルコン インコーポレイティド カスタマイズされた眼科手術プロファイル
JP7189315B2 (ja) * 2019-02-28 2022-12-13 オリンパス株式会社 結石破砕装置、結石破砕システムおよび処置用レーザ光の光量を調節する方法
DE102019135607B4 (de) * 2019-12-20 2023-09-07 Schwind Eye-Tech-Solutions Gmbh Verfahren zur Steuerung eines augenchirurgischen Lasers, sowie Behandlungsvorrichtung
US20220031512A1 (en) 2020-07-31 2022-02-03 Alcon Inc. Systems and methods for eye cataract removal
AU2021403810A1 (en) * 2020-12-16 2023-06-15 Alcon Inc. Adjusting laser pulses to compensate for interfering objects
FR3142882A1 (fr) * 2022-12-12 2024-06-14 Keranova Systeme de decoupe d’un tissu oculaire en portions elementaires

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7131968B2 (en) * 2003-06-02 2006-11-07 Carl Zeiss Meditec Ag Apparatus and method for opthalmologic surgical procedures using a femtosecond fiber laser
WO2007103349A2 (fr) * 2006-03-07 2007-09-13 The Trustees Of Princeton University Dispositifs, procedes et compositions pour corriger une presbytie a l'aide de lasers a impulsions ultracourtes

Family Cites Families (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081207A (en) * 1976-07-01 1978-03-28 Cincinnati Electronics Corporation Scanning lens system
US4481948A (en) 1980-12-29 1984-11-13 Sole Gary M Medical instrument, and methods of constructing and utilizing same
US4633866A (en) * 1981-11-23 1987-01-06 Gholam Peyman Ophthalmic laser surgical method
FR2524298A1 (fr) 1982-04-01 1983-10-07 Essilor Int Appareil de chirurgie ophtalmologique a laser
US4888015A (en) 1982-08-20 1989-12-19 Domino Rudolph S Method of replacing an eye lens
US4638801A (en) * 1983-07-06 1987-01-27 Lasers For Medicine Laser ophthalmic surgical system
US4538608A (en) * 1984-03-23 1985-09-03 Esperance Jr Francis A L Method and apparatus for removing cataractous lens tissue by laser radiation
DE3517667A1 (de) * 1985-05-15 1986-11-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Laser-massenspektrometer
US4766896A (en) * 1986-01-24 1988-08-30 Pao David S C Anterior capsulotomy procedures
US4694828A (en) * 1986-04-21 1987-09-22 Eichenbaum Daniel M Laser system for intraocular tissue removal
US4744360A (en) * 1986-12-18 1988-05-17 Bath Patricia E Apparatus for ablating and removing cataract lenses
WO1989006519A2 (fr) * 1988-01-25 1989-07-27 Refractive Laser Research & Development Program, L Procede et appareil de chirurgie au laser
US4907586A (en) * 1988-03-31 1990-03-13 Intelligent Surgical Lasers Method for reshaping the eye
US5214538A (en) * 1988-07-25 1993-05-25 Keymed (Medical And Industrial Equipment) Limited Optical apparatus
JPH0268055A (ja) * 1988-09-03 1990-03-07 Hoya Corp 眼球内患部の除去装置
US6099522A (en) * 1989-02-06 2000-08-08 Visx Inc. Automated laser workstation for high precision surgical and industrial interventions
US5225862A (en) * 1989-02-08 1993-07-06 Canon Kabushiki Kaisha Visual axis detector using plural reflected image of a light source
US5089022A (en) * 1989-04-26 1992-02-18 The Trustees Of Columbia University In The City Of New York Rectified intraocular lens
US5013319A (en) * 1989-06-05 1991-05-07 Mount Sinai School Of Medicine Of The City University Of New York Apparatus and method for cornea marking
US5036592A (en) * 1990-01-19 1991-08-06 Marshall Forrest A Determining and marking apparatus and method for use in optometry and ophthalmology
JPH0475654A (ja) * 1990-07-19 1992-03-10 Topcon Corp 水晶体嚢レーザー切開装置
US5139022A (en) * 1990-10-26 1992-08-18 Philip Lempert Method and apparatus for imaging and analysis of ocular tissue
US5333018A (en) 1991-01-07 1994-07-26 Heine Optotechnik Gmbh Binocular ophthalmoscope
US6322556B1 (en) 1991-10-30 2001-11-27 Arlene E. Gwon Method of laser photoablation of lenticular tissue for the correction of vision problems
JPH07503382A (ja) 1991-11-06 1995-04-13 ライ，シュイ，ティー． 角膜手術装置及び方法
US5984916A (en) 1993-04-20 1999-11-16 Lai; Shui T. Ophthalmic surgical laser and method
US5269787A (en) 1991-12-17 1993-12-14 Cozean Jr Charles H Apparatus and method for capsulorhexis
US5439462A (en) * 1992-02-25 1995-08-08 Intelligent Surgical Lasers Apparatus for removing cataractous material
US5246435A (en) * 1992-02-25 1993-09-21 Intelligent Surgical Lasers Method for removing cataractous material
JPH08501224A (ja) * 1992-04-10 1996-02-13 プレミア・ラザー・システムズ・インコーポレイテツド 眼球手術の装置と方法
US5261923A (en) 1992-04-23 1993-11-16 Soares Christopher J Method and apparatus for continuous circular capsulorehexis
US5549632A (en) * 1992-10-26 1996-08-27 Novatec Laser Systems, Inc. Method and apparatus for ophthalmic surgery
US5520679A (en) * 1992-12-03 1996-05-28 Lasersight, Inc. Ophthalmic surgery method using non-contact scanning laser
US5336215A (en) * 1993-01-22 1994-08-09 Intelligent Surgical Lasers Eye stabilizing mechanism for use in ophthalmic laser surgery
JPH06304142A (ja) 1993-04-22 1994-11-01 Canon Inc 視線検出装置
US5993438A (en) 1993-11-12 1999-11-30 Escalon Medical Corporation Intrastromal photorefractive keratectomy
US5423841A (en) * 1994-03-15 1995-06-13 Kornefeld; Michael S. Intraocular knife
US5656186A (en) * 1994-04-08 1997-08-12 The Regents Of The University Of Michigan Method for controlling configuration of laser induced breakdown and ablation
US5442412A (en) * 1994-04-25 1995-08-15 Autonomous Technologies Corp. Patient responsive eye fixation target method and system
EP0697611B9 (fr) 1994-08-18 2003-01-22 Carl Zeiss Appareil chirurgical assisté par tomographie de cohérence optique
US6454761B1 (en) 1995-01-30 2002-09-24 Philip D. Freedman Laser surgery device and method
SE9501714D0 (sv) 1995-05-09 1995-05-09 Pharmacia Ab A method of selecting an intraocular lens to be implanted into an eye
US5669923A (en) * 1996-01-24 1997-09-23 Gordon; Mark G. Anterior capsulotomy device and procedure
US7655002B2 (en) * 1996-03-21 2010-02-02 Second Sight Laser Technologies, Inc. Lenticular refractive surgery of presbyopia, other refractive errors, and cataract retardation
US6440146B2 (en) * 1996-07-23 2002-08-27 United States Surgical Corporation Anastomosis instrument and method
US6197018B1 (en) * 1996-08-12 2001-03-06 O'donnell, Jr. Francis E. Laser method for restoring accommodative potential
US6352535B1 (en) * 1997-09-25 2002-03-05 Nanoptics, Inc. Method and a device for electro microsurgery in a physiological liquid environment
AU5120598A (en) * 1996-10-26 1998-05-22 Aesculap-Meditec Gmbh Process and device for shaping surfaces
US5957921A (en) * 1996-11-07 1999-09-28 Optex Ophthalmologics, Inc. Devices and methods useable for forming small openings in the lens capsules of mammalian eyes
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them
DE19734732A1 (de) 1996-12-10 1998-06-18 Wavelight Laser Technologie Gm Vorrichtung für die Behandlung von Körpersubstanzen
US5777719A (en) 1996-12-23 1998-07-07 University Of Rochester Method and apparatus for improving vision and the resolution of retinal images
DE19718139A1 (de) * 1997-04-30 1998-11-05 Aesculap Meditec Gmbh Verfahren und Anordnung zur Phacoemulsifikation
US6010497A (en) * 1998-01-07 2000-01-04 Lasersight Technologies, Inc. Method and apparatus for controlling scanning of an ablating laser beam
US6409718B1 (en) 1998-02-03 2002-06-25 Lasersight Technologies, Inc. Device and method for correcting astigmatism by laser ablation
US6066138A (en) * 1998-05-27 2000-05-23 Sheffer; Yehiel Medical instrument and method of utilizing same for eye capsulotomy
JP2000033097A (ja) * 1998-07-16 2000-02-02 Akira Shibata 外径１．６ｍｍの灌流スリーブ
JP2002522191A (ja) * 1998-08-12 2002-07-23 ライ、ミン 表面切除用パルスレーザービームを走査する方法
US6254595B1 (en) * 1998-10-15 2001-07-03 Intralase Corporation Corneal aplanation device
US6623476B2 (en) 1998-10-15 2003-09-23 Intralase Corp. Device and method for reducing corneal induced aberrations during ophthalmic laser surgery
US6146375A (en) 1998-12-02 2000-11-14 The University Of Michigan Device and method for internal surface sclerostomy
US6344040B1 (en) * 1999-03-11 2002-02-05 Intralase Corporation Device and method for removing gas and debris during the photodisruption of stromal tissue
US6217570B1 (en) * 1999-04-12 2001-04-17 Herbert J. Nevyas Method of aligning the optical axis of a laser for reshaping the cornea of a patients eye with the visual axis of the patient's eye
US6165190A (en) 1999-06-01 2000-12-26 Nguyen; Nhan Capsulectomy device and method therefore
DE19940712A1 (de) 1999-08-26 2001-03-01 Aesculap Meditec Gmbh Verfahren und Vorrichtung zur Behandlung von Trübungen und/oder Verhärtungen eines ungeöffneten Auges
US6391020B1 (en) 1999-10-06 2002-05-21 The Regents Of The Univerity Of Michigan Photodisruptive laser nucleation and ultrasonically-driven cavitation of tissues and materials
US6464666B1 (en) * 1999-10-08 2002-10-15 Augustine Medical, Inc. Intravenous fluid warming cassette with stiffening member and integral handle
US6394999B1 (en) * 2000-03-13 2002-05-28 Memphis Eye & Cataract Associates Ambulatory Surgery Center Laser eye surgery system using wavefront sensor analysis to control digital micromirror device (DMD) mirror patterns
US6652459B2 (en) * 2000-06-28 2003-11-25 Peter Alfred Payne Ophthalmic uses of lasers
DE10100857B4 (de) * 2001-01-11 2006-05-18 Carl Zeiss Jena Gmbh Laserspaltlampe mit Laserstrahlungsquelle
US20080071254A1 (en) * 2001-01-29 2008-03-20 Advanced Medical Optics, Inc. Ophthalmic interface apparatus and system and method of interfacing a surgical laser with an eye
US6899707B2 (en) * 2001-01-29 2005-05-31 Intralase Corp. Applanation lens and method for ophthalmic surgical applications
US6863667B2 (en) * 2001-01-29 2005-03-08 Intralase Corp. Ocular fixation and stabilization device for ophthalmic surgical applications
US6451006B1 (en) 2001-02-14 2002-09-17 20/10 Perfect Vision Optische Geraete Gmbh Method for separating lamellae
DE10108797A1 (de) 2001-02-21 2002-09-05 Zeiss Carl Jena Gmbh Verfahren zur Ermittlung von Abständen am vorderen Augenabschnitt
EP1372552B1 (fr) * 2001-03-27 2017-03-01 WaveLight GmbH Dispositif pour traitement de tissus oculaires et de diagnostic
EP1389070A4 (fr) 2001-04-19 2004-05-12 Intralase Corp Procede et systeme de photocauterisation du tissu de l'oeil
US6579282B2 (en) 2001-04-25 2003-06-17 20/10 Perfect Vision Optische Geraete Gmbh Device and method for creating a corneal reference for an eyetracker
US6533769B2 (en) 2001-05-03 2003-03-18 Holmen Joergen Method for use in cataract surgery
US6702807B2 (en) 2001-09-10 2004-03-09 Minu, L.L.C. Ablatable intracorneal inlay with predetermined refractive properties
US7101364B2 (en) 2001-10-12 2006-09-05 20/10 Perfect Vision Optische Geraete Gmbh Method and apparatus for intrastromal refractive surgery
US7027233B2 (en) * 2001-10-12 2006-04-11 Intralase Corp. Closed-loop focal positioning system and method
US6610051B2 (en) * 2001-10-12 2003-08-26 20/10 Perfect Vision Optische Geraete Gmbh Device and method for performing refractive surgery
US6751033B2 (en) * 2001-10-12 2004-06-15 Intralase Corp. Closed-loop focal positioning system and method
DE10162166A1 (de) * 2001-12-12 2003-06-18 Friedrich Schiller Uni Jena Bu Verfahren zum Entfernen von Abprodukten, die beim Materialabtrag in transparenten Objekten durch laserinduzierte Plasmabildung entstehen
US6712809B2 (en) * 2001-12-14 2004-03-30 Alcon Refractivehorizons, Inc. Eye positioning system and method
DE10202036A1 (de) * 2002-01-18 2003-07-31 Zeiss Carl Meditec Ag Femtosekunden Lasersystem zur präzisen Bearbeitung von Material und Gewebe
US20030171809A1 (en) 2002-03-05 2003-09-11 Phillips Andrew F. Axial-displacement accommodating intraocular lens
US6902561B2 (en) * 2002-03-23 2005-06-07 Intralase Corp. System and method for improved material processing using a laser beam
US6730074B2 (en) * 2002-05-24 2004-05-04 20/10 Perfect Vision Optische Geraete Gmbh Cornea contact system for laser surgery
CN100442006C (zh) * 2002-05-30 2008-12-10 维思克斯公司 跟踪扭转的眼睛的方向和位置
US20040106929A1 (en) * 2002-08-20 2004-06-03 Samuel Masket Method and apparatus for performing an accurately sized and placed anterior capsulorhexis
US20040044355A1 (en) * 2002-08-28 2004-03-04 Nevyas Herbert J. Minimally invasive corneal surgical procedure for the treatment of hyperopia
US7873083B2 (en) 2002-10-17 2011-01-18 Lumenis Ltd. System, method, and apparatus to provide laser beams of two or more wavelengths
DE10300091A1 (de) 2003-01-04 2004-07-29 Lubatschowski, Holger, Dr. Mikrotom
EP1592992B1 (fr) * 2003-01-24 2012-05-30 University of Washington Systeme de balayage a faisceau optique destine a l'affichage ou l'acquisition d'images compact
DE10309440A1 (de) * 2003-03-05 2004-09-16 Robert Bosch Gmbh Verfahren, Vorrichtung und Computerprogramm zum Messen der Leckage von Einspritzsystemen, insbesondere für Brennkraftmaschinen von Kraftfahrzeugen
JP4080379B2 (ja) 2003-05-30 2008-04-23 株式会社ニデック 眼科用レーザ装置
US7351241B2 (en) 2003-06-02 2008-04-01 Carl Zeiss Meditec Ag Method and apparatus for precision working of material
DE50310420D1 (de) 2003-06-10 2008-10-09 Sie Ag Surgical Instr Engineer Ophthalmologische Vorrichtung für die Auflösung von Augengewebe
US7311723B2 (en) * 2003-07-11 2007-12-25 University Of Washington Scanning laser device and methods of use
TWM247820U (en) * 2003-10-17 2004-10-21 Quarton Inc Laser apparatus which can be hung upside down
US8186357B2 (en) * 2004-01-23 2012-05-29 Rowiak Gmbh Control device for a surgical laser
US7402159B2 (en) * 2004-03-01 2008-07-22 20/10 Perfect Vision Optische Geraete Gmbh System and method for positioning a patient for laser surgery
US7238176B2 (en) 2004-04-29 2007-07-03 20/10 Perfect Vision Optische Geraete Gmbh Method for intrastromal photodisruption of dome-shaped surfaces
JP2005323956A (ja) * 2004-05-12 2005-11-24 Shigeo Taniguchi 手術用灌流吸引器具
US7452080B2 (en) * 2004-06-10 2008-11-18 Optimedica Corporation Scanning ophthalmic fixation method and apparatus
US20050284774A1 (en) 2004-06-24 2005-12-29 Mordaunt David H Ophthalmic lens assembly utilizing replaceable contact element
AU2005260743B2 (en) 2004-06-28 2009-01-29 Optimedica Corporation Method and device for optical ophthalmic therapy
DE102004035269A1 (de) * 2004-07-21 2006-02-16 Rowiak Gmbh Laryngoskop mit OCT
US7252662B2 (en) * 2004-11-02 2007-08-07 Lenticular Research Group Llc Apparatus and processes for preventing or delaying one or more symptoms of presbyopia
US8394084B2 (en) * 2005-01-10 2013-03-12 Optimedica Corporation Apparatus for patterned plasma-mediated laser trephination of the lens capsule and three dimensional phaco-segmentation
WO2006078802A1 (fr) 2005-01-21 2006-07-27 Massachusetts Institute Of Technology Procedes et appareil pour le balayage de la tomographie de coherence optique
US7390089B2 (en) * 2005-02-25 2008-06-24 20/10 Perfect Vision Optische Geraete Gmbh Device and method for aligning an eye with a surgical laser
WO2006109255A1 (fr) 2005-04-13 2006-10-19 Safe Surgery Technologies, Llc Instrument de capsulotomie
US20060235428A1 (en) 2005-04-14 2006-10-19 Silvestrini Thomas A Ocular inlay with locator
US7391520B2 (en) 2005-07-01 2008-06-24 Carl Zeiss Meditec, Inc. Fourier domain optical coherence tomography employing a swept multi-wavelength laser and a multi-channel receiver
US20070129775A1 (en) * 2005-09-19 2007-06-07 Mordaunt David H System and method for generating treatment patterns
US10488606B2 (en) * 2005-09-19 2019-11-26 Topcon Medical Laser Systems, Inc. Optical switch and method for treatment of tissue
US10524656B2 (en) * 2005-10-28 2020-01-07 Topcon Medical Laser Systems Inc. Photomedical treatment system and method with a virtual aiming device
US20070121069A1 (en) * 2005-11-16 2007-05-31 Andersen Dan E Multiple spot photomedical treatment using a laser indirect ophthalmoscope
US9681985B2 (en) * 2005-12-01 2017-06-20 Topcon Medical Laser Systems, Inc. System and method for minimally traumatic ophthalmic photomedicine
US7599591B2 (en) * 2006-01-12 2009-10-06 Optimedica Corporation Optical delivery systems and methods of providing adjustable beam diameter, spot size and/or spot shape
US10842675B2 (en) * 2006-01-20 2020-11-24 Lensar, Inc. System and method for treating the structure of the human lens with a laser
US9545338B2 (en) * 2006-01-20 2017-01-17 Lensar, Llc. System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser
US8262646B2 (en) * 2006-01-20 2012-09-11 Lensar, Inc. System and method for providing the shaped structural weakening of the human lens with a laser
US9889043B2 (en) * 2006-01-20 2018-02-13 Lensar, Inc. System and apparatus for delivering a laser beam to the lens of an eye
EP1981426B1 (fr) * 2006-01-20 2020-03-18 LENSAR, Inc. Système permettant d'administrer un faisceau laser dans le cristallin d'un oeil
EP2564769B1 (fr) 2006-04-05 2015-06-03 The General Hospital Corporation Dispositif pour une imagerie de domaine de fréquence optique sensible à la polarisation d'un échantillon
WO2007120755A2 (fr) * 2006-04-11 2007-10-25 Neuroptix Corporation Imagerie oculaire
US8771261B2 (en) * 2006-04-28 2014-07-08 Topcon Medical Laser Systems, Inc. Dynamic optical surgical system utilizing a fixed relationship between target tissue visualization and beam delivery
US20080001320A1 (en) * 2006-06-28 2008-01-03 Knox Wayne H Optical Material and Method for Modifying the Refractive Index
CN101616647B (zh) * 2006-11-10 2013-07-24 拉斯·M·拉森 用于无创或微创光处理眼睛的方法和装置
EP2124713A1 (fr) 2007-02-23 2009-12-02 Mimo AG Appareil ophtalmologique pour imagerie d'un il par tomographie à cohérence optique
US8568393B2 (en) 2007-03-13 2013-10-29 Topcon Medical Laser Systems, Inc. Computer guided patterned laser trabeculoplasty
CN101631522B (zh) * 2007-03-13 2014-11-05 眼科医疗公司 用于创建眼睛手术和松弛切口的装置
WO2009023774A1 (fr) 2007-08-15 2009-02-19 The Cleveland Clinic Foundation Rupture précise d'un tissu en des structures rétiniennes et prérétiniennes
WO2009033110A2 (fr) * 2007-09-05 2009-03-12 Lensx Lasers, Inc. Blindage de protection induit par laser en chirurgie laser
US9456925B2 (en) * 2007-09-06 2016-10-04 Alcon Lensx, Inc. Photodisruptive laser treatment of the crystalline lens
WO2009033107A2 (fr) * 2007-09-06 2009-03-12 Lensx Lasers, Inc. Traitement photodisruptif du cristallin
JP2010538704A (ja) * 2007-09-10 2010-12-16 アルコン レンゼックス， インコーポレーテッド 重力場における有効なレーザ光破壊手術
US20090137991A1 (en) * 2007-09-18 2009-05-28 Kurtz Ronald M Methods and Apparatus for Laser Treatment of the Crystalline Lens
US20090137993A1 (en) * 2007-09-18 2009-05-28 Kurtz Ronald M Methods and Apparatus for Integrated Cataract Surgery
US20100324543A1 (en) 2007-09-18 2010-12-23 Kurtz Ronald M Method And Apparatus For Integrating Cataract Surgery With Glaucoma Or Astigmatism Surgery
US8409182B2 (en) * 2007-09-28 2013-04-02 Eos Holdings, Llc Laser-assisted thermal separation of tissue
US20100324542A1 (en) 2007-11-02 2010-12-23 Kurtz Ronald M Method to Guide a Cataract Procedure by Corneal Imaging
JP2011502585A (ja) * 2007-11-02 2011-01-27 アルコン レンゼックス， インコーポレーテッド 術後の眼の光学的性能を改善するための方法および装置
US20100022996A1 (en) * 2008-07-25 2010-01-28 Frey Rudolph W Method and system for creating a bubble shield for laser lens procedures
US8480659B2 (en) * 2008-07-25 2013-07-09 Lensar, Inc. Method and system for removal and replacement of lens material from the lens of an eye
US8500723B2 (en) * 2008-07-25 2013-08-06 Lensar, Inc. Liquid filled index matching device for ophthalmic laser procedures

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7131968B2 (en) * 2003-06-02 2006-11-07 Carl Zeiss Meditec Ag Apparatus and method for opthalmologic surgical procedures using a femtosecond fiber laser
WO2007103349A2 (fr) * 2006-03-07 2007-09-13 The Trustees Of Princeton University Dispositifs, procedes et compositions pour corriger une presbytie a l'aide de lasers a impulsions ultracourtes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009089504A2 *

Also Published As

Publication number Publication date
EP3363415A1 (fr) 2018-08-22
EP2926780A1 (fr) 2015-10-07
PT3363415T (pt) 2019-11-05
ES2690975T3 (es) 2018-11-23
EP3363415B1 (fr) 2019-10-02
US11026838B2 (en) 2021-06-08
DK3363415T3 (da) 2019-11-25
DE112009000064T5 (de) 2010-11-04
EP2240108B1 (fr) 2015-04-29
US20160331590A1 (en) 2016-11-17
EP2926780B1 (fr) 2018-08-15
US9427356B2 (en) 2016-08-30
WO2009089504A3 (fr) 2009-09-24
TR201815101T4 (tr) 2018-11-21
JP5373820B2 (ja) 2013-12-18
US11654054B2 (en) 2023-05-23
JP2011509162A (ja) 2011-03-24
EP2240108A4 (fr) 2011-09-07
ES2537205T3 (es) 2015-06-03
PT2926780T (pt) 2018-11-07
WO2009089504A2 (fr) 2009-07-16
ES2757628T3 (es) 2020-04-29
US20210322219A1 (en) 2021-10-21
PL3363415T3 (pl) 2020-03-31
DK2926780T3 (en) 2018-12-10
US20140350531A1 (en) 2014-11-27
PL2926780T3 (pl) 2019-01-31
US20090177189A1 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
US11654054B2 (en) Photodisruptive laser fragmentation of tissue
US20210038432A1 (en) System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser
EP3711719B1 (fr) Système pour améliorer l'amplitude d'accommodation et accroître la puissance de réfraction du cristallin humain avec un laser
JP4994847B2 (ja) 手術用レーザの制御装置および水晶体及び／又は角膜処理方法
TWI572347B (zh) 白內障手術與青光眼或散光手術之整合方法與設備
AU2007207513A1 (en) System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser
EP3300706B1 (fr) Variation d'une ouverture numérique d'un laser pendant une fragmentation de cristallin lors d'une chirurgie de la cataracte
AU2016285453B2 (en) Sub-nanosecond laser surgery system utilizing multiple pulsed laser beams
EP2056755B1 (fr) Chirurgie intrastromale permettant de corriger les aberrations d'ordre inférieur et d'ordre supérieur de l'oeil
RU2254844C1 (ru) Способ послойного удаления эпителия роговицы при проведении фоторефрактивной кератэктомии
EP3316832B1 (fr) Système de chirurgie de cataracte à laser de sous-nanoseconde
CN118338871A (zh) 使用具有优化的脉冲能量和扫描线步长的飞秒激光的角膜微透镜切口

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100804

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602009030942

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61B0018200000

Ipc: A61F0009008000

A4 Supplementary search report drawn up and despatched

Effective date: 20110810

RIC1 Information provided on ipc code assigned before grant

Ipc: A61F 9/008 20060101AFI20110804BHEP

17Q First examination report despatched

Effective date: 20110823

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ALCON LENSX, INC.

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20140709

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150202

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: LEMAN CONSULTING S.A., CH

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 724031

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150515

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2537205

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20150603

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602009030942

Country of ref document: DE

Effective date: 20150611

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 724031

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150429

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150831

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150729

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150730

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150829

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009030942

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

Ref country code: RO

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150429

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20160201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160131

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160109

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160109

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: IP PARTNERS J. WENGER, CH

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20090109

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160131

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150429

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20190117

Year of fee payment: 15

Ref country code: NL

Payment date: 20190116

Year of fee payment: 11

REG Reference to a national code

Ref country code: NL

Ref legal event code: PD

Owner name: ALCON INC.; CH

Free format text: DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT; FORMER OWNER NAME: ALCON LENSX, INC.

Effective date: 20191031

REG Reference to a national code

Ref country code: CH

Ref legal event code: PUE

Owner name: ALCON INC., CH

Free format text: FORMER OWNER: ALCON LENSX, INC., US

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20200213 AND 20200219

REG Reference to a national code

Ref country code: ES

Ref legal event code: PC2A

Owner name: ALCON INC.

Effective date: 20200430

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602009030942

Country of ref document: DE

Owner name: ALCON INC., CH

Free format text: FORMER OWNER: ALCON LENSX, INC., ALISO VIEJO, CALIF., US

Ref country code: DE

Ref legal event code: R082

Ref document number: 602009030942

Country of ref document: DE

Representative=s name: K & H BONAPAT PATENTANWAELTE KOCH VON BEHREN &, DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20200201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200131

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200131

REG Reference to a national code

Ref country code: DE

Ref legal event code: R008

Ref document number: 602009030942

Country of ref document: DE

Ref country code: DE

Ref legal event code: R039

Ref document number: 602009030942

Country of ref document: DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R040

Ref document number: 602009030942

Country of ref document: DE

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230504

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231221

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20231222

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240206

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20231220

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20231228

Year of fee payment: 16